# Safety and Efficacy Study of Pilocarpine HCl Ophthalmic Solution in Participants With Presbyopia

> **NCT06451666** · PHASE3 · NOT_YET_RECRUITING · sponsor: **CSPC Ouyi Pharmaceutical Co., Ltd.** · enrollment: 330 (estimated)

## Conditions studied

- Presbyopia

## Interventions

- **DRUG:** Pilocarpine HCl Ophthalmic Solution
- **DRUG:** Vehicle

## Key facts

- **NCT ID:** NCT06451666
- **Lead sponsor:** CSPC Ouyi Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-06-30
- **Primary completion:** 2025-11-30
- **Final completion:** 2025-12-30
- **Target enrollment:** 330 (ESTIMATED)
- **Last updated:** 2024-07-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06451666

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06451666, "Safety and Efficacy Study of Pilocarpine HCl Ophthalmic Solution in Participants With Presbyopia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06451666. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*